GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RAMM Pharma Corp (XCNQ:RAMM) » Definitions » Equity-to-Asset

RAMM Pharma (XCNQ:RAMM) Equity-to-Asset : 0.80 (As of Jan. 2025)


View and export this data going back to 2019. Start your Free Trial

What is RAMM Pharma Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. RAMM Pharma's Total Stockholders Equity for the quarter that ended in Jan. 2025 was C$12.43 Mil. RAMM Pharma's Total Assets for the quarter that ended in Jan. 2025 was C$15.55 Mil. Therefore, RAMM Pharma's Equity to Asset Ratio for the quarter that ended in Jan. 2025 was 0.80.

The historical rank and industry rank for RAMM Pharma's Equity-to-Asset or its related term are showing as below:

XCNQ:RAMM' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.03   Med: 0.92   Max: 0.96
Current: 0.8

During the past 7 years, the highest Equity to Asset Ratio of RAMM Pharma was 0.96. The lowest was -0.03. And the median was 0.92.

XCNQ:RAMM's Equity-to-Asset is ranked better than
81.05% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 0.61 vs XCNQ:RAMM: 0.80

RAMM Pharma Equity-to-Asset Historical Data

The historical data trend for RAMM Pharma's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RAMM Pharma Equity-to-Asset Chart

RAMM Pharma Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Equity-to-Asset
Get a 7-Day Free Trial 0.96 0.94 0.91 0.91 0.81

RAMM Pharma Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.92 0.92 0.93 0.81 0.80

Competitive Comparison of RAMM Pharma's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, RAMM Pharma's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RAMM Pharma's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RAMM Pharma's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where RAMM Pharma's Equity-to-Asset falls into.


;
;

RAMM Pharma Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

RAMM Pharma's Equity to Asset Ratio for the fiscal year that ended in Oct. 2024 is calculated as

Equity to Asset (A: Oct. 2024 )=Total Stockholders Equity/Total Assets
=13.635/16.749
=0.81

RAMM Pharma's Equity to Asset Ratio for the quarter that ended in Jan. 2025 is calculated as

Equity to Asset (Q: Jan. 2025 )=Total Stockholders Equity/Total Assets
=12.43/15.55
=0.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RAMM Pharma  (XCNQ:RAMM) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


RAMM Pharma Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of RAMM Pharma's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


RAMM Pharma Business Description

Traded in Other Exchanges
N/A
Address
82 Richmond Street E, Toronto, ON, CAN, M5C 1P1
RAMM Pharma Corp is engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. The group generates revenue from the sale of medical devices and consumables, the sale of pharmaceutical products, and sale of cosmetics. Geographically, it derives a majority of its revenue from Uruguay.
Executives
Jackie Peter Burnett 10% Security Holder, Director, Senior Officer
Armando Gabriel Blankleider Director

RAMM Pharma Headlines

No Headlines